OTTO BONIN: Open Payments
NPI 1558368316 · ZACHARY, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$933 in 49 payments from 16 companies in 2025. Trend: 2023 $543 · 2024 $945 · 2025 $933
Food & beverage: $933
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $277 |
| AstraZeneca Pharmaceuticals LP | 8 | $145 |
| Lilly USA, LLC | 5 | $94 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $64 |
| Abbott Laboratories | 3 | $62 |
| Novo Nordisk Inc | 3 | $54 |
| PFIZER INC. | 2 | $44 |
| Exact Sciences Corporation | 2 | $37 |
| Axsome Therapeutics, Inc. | 1 | $31 |
| GlaxoSmithKline, LLC. | 1 | $23 |
Products named: QULIPTA, AIRSUPRA, MOUNJARO, VRAYLAR, CAPLYTA, FREESTYLE LIBRE 3, ELIQUIS, Cologuard Collection Kit.
Industry payments across LA — which companies pay providers there.
